Australian court rules that Nurofen owner misled consumers over pain relief

An Australian court has ordered Nurofen’s UK owner to stop selling several versions of the popular painkiller that were identical to its standard ibuprofen pills but nearly twice as expensive.

The Federal Court ruled that British consumer goods company Reckitt Benckiser deceived Australians by selling Nurofen painkillers that were marketed to relieve specific ailments, such as back pain, when all of the products contained an identical amount of the same active ingredient, ibuprofen lysine.